Increased expression of mast cell chymase in the lungs of patients with congenital heart disease associated with early pulmonary vascular disease

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 4, 1999, Pages 1303-1308

  Hamada, Hiromichi ^a,b   Terai, Masaru ^a,b   Kimura, Hiroshi ^a,b   Hirano, Kiyomi ^a,b   Oana, Shinji ^a,b   Niimi, Hiroo ^a,b  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Chiba Cardiovascular Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; CHYMASE;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; LUNG BIOPSY; LUNG BLOOD FLOW; LUNG PRESSURE; LUNG VASCULAR RESISTANCE; MAST CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PULMONARY ARTERY DISEASE; TISSUE DISTRIBUTION;

EID: 0032877551     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.4.9810058     Document Type: Article

References (35)

1. Heath. D., and J. E. Edwards. 1958. The pathology of hypertensive pulmonary vascular disease: a description of six guides of structural changes in the pulmonary artery with special reference to congenital cardiac detect. Circulation 18:533-547.
2. Haworth, S. G. 1987. Pulmonary vascular disease in ventricular septal defect: structural and functional correlations in lung biopsies from 85 patients, with outcome of intra-cardiac repair. J. Pathol. 152:157-168.
3. Rabinovitch, M. 1995. Pathophysiology of pulmonary hypertension. In G. C. Emmanouilides, T. A. Riemenschneider, H. D. Allen, and H. P. Gutgesell, editors. Heart Disease in Infants, Children, and Adolescents, Williams and Wilkins. Baltimore. 1659-1695.
4. Gordon, J. R., P. R. Burd, and S. J. Galli. 1990. Mast cells as a source of multifunctional cytokines. Immunol. Today 11:458-464.
5. Galli, S. J. 1992. New concepts about the mast cell. N. Engl. J. Med. 328:257-265.
6. Galli, S. J. 1990. New insights into "The riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab. Invest. 62:5-33.
7. Irani, A. A., N. M. Schechter, S. S. Craig, G. Deblois, and L. B. Schwartz. 1986. Two types of human mast cells that have distinct neutral protease compositions. Proc. Natl. Acad. Sci. U.S.A. 83:4464-4468.
8. Schwartz, L. B. 1989. Heterogeneity of mast cells in humans. In S. J. Galli, and K. F. Austen, editors. Mast Cell and Basophil Differentiation and Function in Health and Disease. Raven Press, New York. 93-105.
9. Kitamura, Y. 1989, Heterogeneity of mast cells and phenotypic changes between subpopulations. Annu. Res. Immunol. 7:56-76.
10. Wintroub, B. U. C. E. Kaempfer. N. M. Schechter, and D. Proud. 1986. A human lung mast cell chymotryptic-like enzyme: identification and partial characterization. J. Clin, Invest. 77:196-201.
11. Urata, H., K. D. Boehm, A. Philip, A. Kinoshita, J. Gabrovsek, F. M. Bumpus, and A. Husain. 1993. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J. Clin. Invest. 91:1269-1281.
12. Urata. H., B. Healy, R. W. Stewart, F. M. Bumpus, and A. Husain. 1990. Angiotensin II-forming pathways in normal and failing human hearts. Circ. Res. 66:883-890.
13. Shiota, N., H. Okunishi, A. Fukamizu, H. Sakonjo, M. Kikumori, T. Nishimura, T. Nakagawa, K. Murakami, and M. Miyazaki. 1993. Activation of two angiotensin-generating systems in the balloon-injured artery. FEBS. Lett. 323:239-242.
14. Okunishi, B., M. Miyazaki, T. Okamura, und N. Toda. 1987. Different distribution of two types of angiotensin II generating enzymes in the aortic wall. Biochem. Biophys. Res. Commun. 149:1186-1192.
15. Okunishi, H., Y. Oka, and N. Shiota. 1993. Marked species difference in the vascular angiotensin II-forming pathways: humans versus rodents. Jpn. J. Pharmacol. 62:207-210.
16. Geisterfer, A. A. T., M. J. Peach, and G.K. Owens. 1988. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 62:749-756.
17. Gibbons, G. H., R. E. Pratt, and V. J. Dzau. 1992. Vascular smooth muscle cell hypertrophy vs. hyperplasia: autocrine transforming growth factor-β1 expression determines growth response to angiotensin II. J. Clin. Invest. 90:456-461.
18. Berk, H. C., and M. A. Corson. 1997. Angiotensin II signal transduction in vascular smooth muscle. Circ Res. 80:607-616.
19. Morrell, N. W., E. N. Atochina, K. G. Morris. S. M. Danilov, and K. R. Stenmark. 1995. Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension, J. Clin. Invest. 96:1823-1833.
20. Morrell, N. W., K. G. Morris, and K. R. Stenmark. 1995. Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. Am. J. Physiol. 269:H1186 H1194
21. Lafarge, C. G., and O. S. Miettinen. 1970. The estimation of oxygen consumption, Cardiovasc. Res. 4:23-30.
22. Terai, M., Y. Kohno, M. Namba, T. Umemiya, K. Niwa, H. Nakajima, and A. Mikata. 1990. Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease. Hum. Pathol. 21:231-234.
23. Lindstedt, L., M. Lee, G. R. Castro, J. C. Fruchart, and P. T. Kovanen. 1996. Chymase in exocytosed rat mast cell granules effectively proteolyses apolipoprotein A1-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid. J. Clin. Invest. 97:2174-2182.
24. Kokkonen, J. O., and P. T. Kovanen. 1989. Proteolytic enzymes of mast cell granules degrade low density lipoproteins and promote their granule-mediated uptake by macrophages in vitro. J. Biol. Chem. 264:10749-10755.
25. Kovanen, P. T., M. Kaartinen, and T. Panvonen. 1995. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 92:1084-1088.
26. Hunt, L. W., T. V. Colby, W. A. Weiler, S. Sur, and J. H, Butterfield. 1992. Immunofluorescent staining for mast cells in idiopathic pulmonary fibrosis: quantification and evidence for extracellular release of mast cell tryptase. Mayo Clin. Proc. 67:941-948.
27. Chanez, P., J. Y. Lacoste, B. Guillot, J. Giron, G. Barneon, I. Enander, P. Godard, F. B. Michel, and L. Bousquet. 1993. Mast cell's contribution to the fibrosing alveolitis of scleroderma lung. Am. Rev. Respir. Dis. 147:1497-1502.
28. Heath, D., and M. Yacoub. 1991, Lung mast cells in plexogenic pulmonary arteriopathy. J. Clin. Pathol. 44:1003-1006.
29. Wagenvoot, C. A. 1977. Normal pulmonary and bronchial structure. In C. A. Wagenvoot and N. Wagenvoot. editors. Pathology of Pulmonary Hypertension. John Wiley and Sons, Inc., New York. 17-55.
30. Lagunoff, D., and P. Pritzl. 1976. Characterization of rat mast cell granule protein. Arch. Biochem, Biophys. 173:554-563.
31. Woodbury, R. G., M. T. Everitt, and H. Neurath. 1981. Mast cell proteases. Methods Enzymol. 80:588-609.
32. Shiota, N., D. Jin, S. Takai, T. Kuwamura, M. Koyama, T. Nakamura, M. Miyazaki. 1997. Chymase is activated in the hamster heart following ventricular fibrosis during the chronic stage of hypertension. FEBS. Lett. 406:301-304.
33. Sayama. S., R. V. Lozzo, G. S. Lazaus, and N. M. Schechter. 1987. Human skin chymotrypsin-like protease chymase, subcellular localization to mast cell granules and interaction with heparin and other glycosaminoglycans. J. Biol. Chem. 262:6808-6815.
34. Rabinovitch, M., T. Bothwell, B. N. Hayakawa, W. G. Williams, G. A. Truser, R. D. Rowe, P. M. Olley, and E. Cutz. 1986. Pulmonary artery endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension: a correlation of light microscopy and transmission electron microscopy. Lab. Invest. 55:632-653.
35. Hall, S. M., and S. G. Haworth. 1992. Onset and evolution of pulmonary vascular disease in young children: abnormal postnatal remodeling studied in lung biopsies. J. Pathol 166:183-193.